Clinical Trials · NCT00458458
Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg)
- Phase
- Phase 3
- Recruitment status
- Unknown
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Enrollment
- 112
- Start date
- Aug 2004
- Locations
- 1 site, United States
- Primary endpoint
- To compare the effectiveness of norethindrone acetate (NA) with GnRH agonist (Lupron-Depot-3) in relieving symptoms of endometriosis